SC
NVO

Settian Capital’s Novo Nordisk NVO Stock Holding History

Settian Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,000
Closed -$1.66M – 26
2025
Q3 		$1.66M Hold
30,000
– – 1.13% 20
2025
Q2 		$2.07M Hold
30,000
– – 1.46% 19
2025
Q1 		$2.08M Hold
30,000
– – 1.62% 18
2024
Q4 		$2.58M Hold
30,000
– – 1.86% 14
2024
Q3 		$3.57M Hold
30,000
– – 2.6% 15
2024
Q2 		$4.28M Hold
30,000
– – 3.14% 10
2024
Q1 		$3.85M Hold
30,000
– – 2.86% 12
2023
Q4 		$3.1M Buy
30,000
+14,000
+88% +$1.38M 2.48% 11
2023
Q3 		$1.46M Hold
16,000
– – 1.23% 28
2023
Q2 		$1.29M Buy
+16,000
New +$1.31M 1.08% 30

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Settian Capital's NVO Position: Q4 2025 in Review

Settian Capital sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 30,000 shares — an estimated $1.66M sold.

Settian Capital first reported a position in NVO in Q2 2023 and held it in 10 quarters. The position peaked at $4.28M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Settian Capital reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Settian Capital sold 30,000 Novo Nordisk shares in Q4 2025, an estimated $1.66M.
  • Settian Capital first reported a position in Novo Nordisk in Q2 2023 and held it in 10 quarters.
  • Settian Capital's Novo Nordisk position peaked at $4.28M in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Settian Capital's 13F filing for Q4 2025, filed 4 Feb 2026.